In a retrospective cohort study, we investigated the behavior of VF tests (as a function of time) of 277 eyes of 139 patients with glaucoma who were recruited from the Rotterdam Eye Hospital in the Netherlands. All subjects filled in the written consent form and the study was approved by the Institutional Review Board of Rotterdam Eye Hospital. Patients aged 18 to 85 years old were examined. Patients with uveitic glaucoma, secondary glaucoma, except pigmentary, evidence of SAP VF abnormality consistent with other disease, best-corrected visual acuity (BCVA) >0.3 (LogMAR), refractive error outside −10.0 to +5.0 diopters (D) range, cataract surgery in previous 12 months, previous refractive or vitreoretinal surgery, evidence of diabetic retinopathy, diabetic macular edema, or other vitreo-retinal disease, previous keratoplasty surgery, diabetes, leukemia, AIDS, uncontrolled systemic hypertension, multiple sclerosis, or (other) life-threatening disease were excluded from the study.
24 Demographic information, including sex, age, and baseline intraocular pressure (IOP) was collected. Individuals were tested every 6 months and at each visit, SAP was performed using Humphrey Visual Field Analyzers (Carl Zeiss Meditec) with a standard white-on-white 24-2 field with the full threshold program. Tests with greater than 33% fixation losses, 20% false-negative or false-positive error rates were excluded (a full description of data is available at
http://rod-rep.com).
The values of 52 VF test locations were considered as the outcome of interest and utilized in the analysis, except for locations with the initial 3 values equal to 0 dB. Moreover, patients with fewer than 15 visits were excluded from the study. The linear, exponential, and sigmoid regression models were utilized to investigate the pattern of threshold sensitivity deterioration at each VF test location during the follow-up time for each eye.
In the next step, linear, exponential, and sigmoid regressions were applied to assess the rate of deterioration at each Glaucoma Hemifield Test (GHT) sector.
25 In this approach, the superior and inferior hemifields were divided into 10 glaucoma regions named
Arcuate1,
Arcuate2,
Nasal,
Central, and
Paracentral. Each sector consisted of three to five VF test locations; therefore, we calculated the mean of threshold sensitivity in each region to regress it against age in predefined models mentioned above.